MannKind | Rentekostnader



Interest Expense On Debt Endring Dato
Adma Biologics USD 3.5M 284K 2024-09
Dynavax Technologies USD 1.7M 5K 2024-12
Eli Lilly USD 224.7M 78.4M 2024-12
Halozyme Therapeutics USD 4.54M 16K 2024-12
Insmed USD 19.8M 532K 2024-12
MacroGenics USD 0 6K 2024-09
MannKind USD 7.48M 879K 2024-12
Merck USD 328M 2M 2024-12
Pfizer USD 739M 45M 2024-12
Sanofi 62M 17M 2024-12
Xencor -39359000 40.15M 2024-12



MannKind Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.